Clinical Resources and Guidance
Testing
Therapeutics
Oral Antivirals
Paxlovid
Molnupiravir
Monoclonal Antibodies
Bebtelovimab
Sotrovimab
Evusheld (tixagevimab co-packaged with cilgavimab)
Casirivamab/imdevimab – Currently NOT authorized due to inactivity against the Omicron variant
Bamlanivimab/etesivimab – Currently NOT authorized due to inactivity against the Omicron variant
PPE Guidance, Templates and Videos – The University of Kansas Health System
PPE Resources and Guidance